Dynavax Technologies (DVAX)
$9.82
0.22 (2.29%)
DVAX Stock Quote Delayed 30 Minutes
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Welcome back, trader! I hope the weekend served you well because we've got pre-market stock movers to start off Monday with!
11 Best Stocks to Buy for 2022
He found Apple at $1.49... Oracle at $0.51... Amazon at $46. Now, investing legend Louis Navellier is revealing his Top 11 Stocks for 2022 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
1.23B
PE Ratio
17.54
EPS
0.56
Volume (Avg. Vol.)
29.43M
Day's Range
$9.42 - $10.12
52-Week Range
$7.26 - $21.39
Dividend & Yield
N/A (N/A)
DVAX Stock Predictions, Articles, and Dynavax Technologies News
Be Careful with Novavax and the Recent Surge in NVAX Stock
Covid-19 vaccine stocks are on fire, but many of them appear to be out over their skis, including the group's hottest name, NVAX stock.
7 Strong Buy Stocks Analysts Are Upgrading Now, Including Facebook, Inc.
Here we dig down into seven intriguing stock rating upgrades from the Street. Why now? Why are analysts turning bullish on these stocks? All seven of these stocks share a 'Strong Buy' analyst consensus rating from the Street. The result: you can be confident that these stocks are the crème de la crème.
Wendy’s Co (WEN) and Kate Spade & Co (KATE) Lead 16 Activist Investor Filings
13G and 13D filings are windows into the activities of activist investors. Today's we look at Kate Spade & Co and 15 other filings
Dynavax Technologies Corporation (DVAX) Stock Earns a Double-Digit Lift
Dynavax's SD-101 just got through a Phase 1b/2 clinical trial with a trio of positive points, sending DVAX stock up by double digits Monday.
Hottest Manufacturing Stocks Now – FLKS EGLT VSAR DVAX
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Biggest Movers in Manufacturing Stocks Now – GLF REPH BOSC ADMP
The following stocks were moving the Manufacturing sector today.
Hottest Manufacturing Stocks Now – REPH XXIA CEMP EBIO
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Hottest Manufacturing Stocks Now – FTK SPCB TESO SCX
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
Hottest Manufacturing Stocks Now – FATE EPZM RGNX VHI
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Biggest Movers in Manufacturing Stocks Now – LEDS PXLW FATE DVAX
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
Hottest Manufacturing Stocks Now – DVAX AUPH ZBRA NTLA
The following stocks were moving the Manufacturing sector today.
Why Dynavax Technologies Corporation (DVAX), Petroleo Brasileiro SA Petrobras (ADR) (PBR) and Puma Biotechnology Inc (PBYI) Are 3 of Today’s Worst Stocks
Dynavax (DVAX), Puma (PBYI) and Petrobras (PBR) shareholders got a miserable start to the new trading week. Here's what you need to know.
Biggest Movers in Manufacturing Stocks Now – CRBP CRDS EBIO MTL
The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.
52 Biotechnology Stocks to Sell Now
The overall ratings of 52 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
30 Biotechnology Stocks to Sell Now
The ratings of 30 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
